Niagen Bioscience (NAGE)

• Market cap: $384M
• 1 day: 0.42%
• 5 days: -6.25%
• 1 month: -8.75%
• 3 months: -24.29%
• 6 months: -49.42%
• Year to date: -23.2%
• 1 year: -39.55%
• 5 years: -63.11%
• 10 years: 7.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 117